JANNEY DANIEL

Average Profitability
34.94%
Insider Buys Quantity
4
Insider Buys Sum
$39.6M
Insider Sells Quantity
16
Insider Sells Sum
$62.36M

Insider Activity of JANNEY DANIEL

The largest purchase of all time was on 2014-10-21 and amounted to 1000000 shares of Esperion Therapeutics, Inc. for $20M.

The largest sale of all time was on 2017-03-21 and amounted to 700000 shares of Esperion Therapeutics, Inc. for $32.06M.

Biography of JANNEY DANIEL

No biography is available at this moment.

2023-06-09SaleKrystal Biotech, Inc.
KRYS
director
18,935
0.0736%
$128.77$2.44M-4.32%
2023-06-08SaleKrystal Biotech, Inc.
KRYS
director
31,065
0.1209%
$128.11$3.98M-3.61%
2023-05-19SaleKrystal Biotech, Inc.
KRYS
director
50,000
0.1924%
$95.02$4.75M+26.32%
2023-05-09SaleKrystal Biotech, Inc.
KRYS
director
17,100
0.0657%
$90.74$1.55M+31.03%
2023-04-19SaleKrystal Biotech, Inc.
KRYS
director
7,900
0.0311%
$90.32$713,493+33.54%
2021-12-10SaleKrystal Biotech, Inc.
KRYS
director
100,000
0.4439%
$70.50$7.05M-3.35%
2021-03-26SaleAllakos Inc.
ALLK
17,308
0.0325%
$115.17$1.99M-26.7%
2021-03-22SaleAllakos Inc.
ALLK
13,148
0.025%
$119.70$1.57M-28.5%
2021-03-15SaleAllakos Inc.
ALLK
6,708
0.0128%
$124.56$835,548-29.98%
2021-03-12SaleAllakos Inc.
ALLK
4,071
0.0077%
$124.18$505,537-29.68%
2021-03-11SaleAllakos Inc.
ALLK
6,006
0.0114%
$124.62$748,468-29.45%
2021-03-09SaleAllakos Inc.
ALLK
100
0.0002%
$125.00$12,500-25.92%
2019-08-30SaleKrystal Biotech, Inc.
KRYS
director
64,380
0.191%
$23.09$1.49M+4.29%
2019-08-29SaleKrystal Biotech, Inc.
KRYS
director
112,988
0.327%
$23.31$2.63M+0.71%
2018-07-23PurchaseAllakos Inc.
ALLK
500,000
0.7605%
$18.00$9M+13.36%
2017-09-22PurchaseKrystal Biotech, Inc.
KRYS
director
400,000
9.5053%
$10.00$4M+1.89%
2017-03-21SaleEsperion Therapeutics, Inc.
ESPR
director
700,000
3.6385%
$45.80$32.06M+24.97%
2014-10-21PurchaseEsperion Therapeutics, Inc.
ESPR
1M
5.3572%
$20.00$20M+170.46%
2013-07-01PurchaseEsperion Therapeutics, Inc.
ESPR
director
471,428
3.072%
$14.00$6.6M+8.67%
2006-11-14SaleDynavax Technologies Corporation
DVAX
No longer a Director
4,970
0.0123%
$6.05$30,074-20.75%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.